ERGOMED GROUP LIMITED
Get an alert when ERGOMED GROUP LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-06-24 (in 1mo)
Last made up 2025-06-10
Watchouts
Cash
£2M
-23.9% vs 2023
Net assets
£77M
+15.7% vs 2023
Employees
74
-3.9% vs 2023
Profit before tax
£24M
-0.3% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
4 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Name history
Renamed 4 times since incorporation
- ERGOMED GROUP LIMITED 2023-12-12 → present
- ERGOMED GROUP PLC 2023-12-12 → 2023-12-12
- ERGOMED PLC 2014-06-06 → 2023-12-12
- ERGOMED CLINICAL RESEARCH PLC 2014-06-06 → 2014-06-06
- ERGOMED CLINICAL RESEARCH LIMITED 2000-09-29 → 2014-06-06
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £53,460,415 | £60,627,041 | |
| Operating profit | -£18,385,727 | £2,618,728 | |
| Profit before tax | £24,049,800 | £23,978,146 | |
| Net profit | £20,860,658 | £23,835,305 | |
| Cash | £2,393,042 | £1,821,511 | |
| Total assets less current liabilities | £66,773,818 | £77,289,304 | |
| Net assets | £66,773,818 | £77,289,304 | |
| Equity | £66,773,818 | £77,289,304 | |
| Average employees | 77 | 74 | |
| Wages | £6,849,504 | £5,193,120 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -34.4% | 4.3% | |
| Net margin | 39.0% | 39.3% | |
| Return on capital employed | -27.5% | 3.4% | |
| Gearing (liabilities / total assets) | 42.5% | 40.7% | |
| Current ratio | 0.41x | 0.43x | |
| Interest cover | -32.94x | 1277.43x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have prepared the financial statements on the going concern basis as they do not intend to liquidate the Company or to cease its operations, and as they have concluded that the Company's financial position means that this is realistic. They have also concluded that there are no material uncertainties that could have cast significant doubt over its ability to continue as a going concern for at least a year from the date of approval of the financial statements ("the going concern period").”
Group structure
- ERGOMED GROUP LIMITED · parent
- Ergomed d.o.o. Sarajevo
- Ergomed Bulgaria EOOD
- Ergomed istraživanja Zagreb d.o.o.
- PrimeVigilance s.r.o.
- Ergomed CDS GmbH
- Ergomed GmbH
- Ergomed Clinical Research Private Limited
- Ergomed B.V.1
- Ergomed Sp. z o.o.
- Ergomed Clinical Research Russia LLC
- Ergomed d.o.o. Beograd
- Ergomed Clinical Research Spain, S.L.
- ERGOMED Virtuoso Sarl
- ADAMAS Consulting Group Limited2
- Ergomed Clinical Research Limited
- Haemostatix Limited
- PrimeVigilance Limited
- Ergomed Clinical Research, Inc.3
- Ergomed Pharmaceutical Services Inc.4
- PrimeVigilance Zagreb d.o.o.
- Pharminvent regulatory s.r.o.
- Ergomed France SAS5
- PrimeVigilance GmbH
- ADAMAS Clinical Quality Consulting Private Limited2
- Ergomed Limited6
- Ergomed S.r.l7
- PrimeVigilance Japan K.K.
- Servicos Farmaceuticos PrimeVigilance, Unipessoal Lda.8
- Servicii Farmaceutice Ergomed S.r.l.9
- PrimeVigilance d.o.o. Beograd-Novi Beograd
- ADAMAS Consulting Limited2
- Medsource UK Limited
- Pharmacovigilance Services Limited
- Ergomed US Holdings Limited
- ADAMAS Consulting LLC2
- MS Clinical Services, LLC
- PrimeVigilance Inc.
- PrimeVigilance USA Inc.
- Ergomed US Holdings Inc.
- PrimeVigilance Limited (formerly Panacea Pharma Projects Limited)
Significant events
- “On 1 April 2025, the company completed the acquisition of 100% of the share capital of Prudentia Consulting India Private Limited ("Prudentia"). Prudentia provide management and technology consulting services to the pharmaceutical industry advising companies on processes and technologies in support of clinical and post marketing safety and surveillance. Ergomed Group Limited has a 12-month measurement period from the date of acquisition ending on 1 April 2026.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 33 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JACKSON, Alaric Richard Warwick | Director | 2026-05-08 | Oct 1976 | British |
| JAVEED, Zubair | Director | 2025-12-19 | May 1972 | British |
Show 33 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BLETCHER, Joanne | Secretary | 2019-09-18 | 2025-12-31 |
| CARNEY, John | Secretary | 2004-10-25 | 2005-08-22 |
| CLARK, Neil Robert | Secretary | 2014-06-06 | 2016-05-01 |
| JURIC, Sanja | Secretary | 2016-05-04 | 2019-09-18 |
| CARGIL MANAGEMENT SERVICES LIMITED | Corporate Secretary | 2005-08-22 | 2010-10-14 |
| DEANS COURT REGISTRARS LIMITED | Corporate Secretary | 2003-09-23 | 2004-10-25 |
| LEGAL SECRETARIES LIMITED | Corporate Nominee Secretary | 2000-09-29 | 2000-10-02 |
| TYLNEY SECRETARIES LIMITED | Corporate Secretary | 2001-07-01 | 2003-09-23 |
| BARFIELD, Richard Timothy | Director | 2019-06-18 | 2023-02-03 |
| CAMERON, Lewis | Director | 2020-01-20 | 2020-09-21 |
| CLARK, Neil Robert | Director | 2010-01-29 | 2017-04-16 |
| COLLINS, Christopher Irvin | Director | 2014-07-15 | 2019-03-08 |
| CURTAIN, Jonathan Andrew, Mr. | Director | 2023-02-03 | 2025-07-31 |
| DAWSON, John Andrew | Director | 2022-03-08 | 2023-11-13 |
| ENYEDY, Mark Joseph | Director | 2021-06-10 | 2023-11-13 |
| ESINHART, James, Dr | Director | 2019-07-19 | 2020-05-14 |
| GEORGE, Peter | Director | 2014-05-20 | 2019-09-24 |
| JACKSON, Stuart Robert | Director | 2018-07-02 | 2019-06-18 |
| JOHNSON, Ian Roy | Director | 2019-08-19 | 2021-04-28 |
| KELTNER, Llew, Dr | Director | 2021-04-28 | 2023-11-13 |
| MACKIE, Andrew | Director | 2015-07-01 | 2018-10-01 |
| PETRACEK, Jan | Director | 2017-12-14 | 2019-09-17 |
| PRETORIUS, Sybrand Gerhardus | Director | 2024-08-07 | 2025-12-19 |
| RELJANOVIC, Miroslav | Director | 2001-04-25 | 2026-04-29 |
| SODERSTROM, Rolf Kristian Berndtson | Director | 2019-07-19 | 2021-09-30 |
| SPITERI, Michael | Director | 2018-10-01 | 2022-11-16 |
| STAHEL, Rolf | Director | 2014-04-18 | 2017-03-31 |
| STAMP, Stephen Anthony | Director | 2016-01-11 | 2019-01-22 |
| WENG, Dan, Dr | Director | 2017-07-01 | 2017-12-14 |
| WHITAKER, Anne Michelle Clem | Director | 2022-06-10 | 2023-11-13 |
| LEGAL DIRECTORS LTD (COMP NBR 3368733) | Corporate Nominee Director | 2000-09-29 | 2000-10-02 |
| TYLNEY DIRECTORS LIMITED | Corporate Director | 2000-11-30 | 2001-07-01 |
| TYLNEY SECRETARIES LIMITED | Corporate Director | 2000-11-30 | 2001-07-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Eden Acquisitionco Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-11-13 | Active |
| Mr Miroslav Reljanovic | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2019-10-30 |
Filing timeline
Last 20 of 283 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-11 | AP01 | officers | Appoint person director company with name date | |
| 2026-05-11 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-05 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-12-24 | CH01 | officers | Change person director company with change date | |
| 2025-12-23 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-23 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-18 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-11-13 | SH01 | capital | Capital allotment shares | |
| 2025-10-03 | AA | accounts | Accounts with accounts type full | |
| 2025-10-03 | SH01 | capital | Capital allotment shares | |
| 2025-08-12 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-10 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-04-11 | SH01 | capital | Capital allotment shares | |
| 2024-11-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-11-14 | AD04 | address | Move registers to registered office company with new address | |
| 2024-11-14 | AD02 | address | Change sail address company with old address new address | |
| 2024-11-14 | AD03 | address | Move registers to sail company with new address | |
| 2024-10-05 | AA | accounts | Accounts with accounts type group | |
| 2024-08-21 | AP01 | officers | Appoint person director company with name date | |
| 2024-02-15 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 12
- Capital events
- 3
- Officers appointed
- 2
- Officers resigned
- 4
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+13.4%
£53,460,415 £60,627,041
-
Cash
-23.9%
£2,393,042 £1,821,511
-
Net assets
+15.7%
£66,773,818 £77,289,304
-
Employees
-3.9%
77 74
-
Operating profit
+114.2%
-£18,385,727 £2,618,728
-
Profit before tax
-0.3%
£24,049,800 £23,978,146
-
Wages
-24.2%
£6,849,504 £5,193,120
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers